Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FX1LJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,049
Award facts
- Contract value 100% obligated
- $17,048.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,048.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 68 mg Nexplanon implants on November 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order will be performed in Park Ridge, Illinois, with an ultimate completion date of December 4, 2025.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The IDC, valued at $499,999,999 with a completion date of December 31, 2036, was awarded on November 13, 2025, and authorizes DLA to issue firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. The PPV-G GEN V represents a $30.3 billion acquisition strategy, and DMS Pharmaceutical Group serves as one of multiple regional prime vendor contractors supplying military healthcare facilities globally with branded and generic prescription drugs, biologics, and related medical products.
Quick answers
Who was awarded contract SPE2DB26FX1LJ?
SPE2DB26FX1LJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FX1LJ worth?
The government has obligated $17,049 on SPE2DB26FX1LJ.
Is contract SPE2DB26FX1LJ an order under another contract?
Yes. SPE2DB26FX1LJ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1LJ competed?
The extent of competition for SPE2DB26FX1LJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award